Esperion Therapeutics: Fourth Quarter Earnings Overview

Esperion Therapeutics Announces Fourth Quarter Financial Results

Esperion Therapeutics Inc., headquartered in Ann Arbor, Michigan, revealed a net profit of $61.8 million for the fourth quarter.

The company's earnings translated to 22 cents per share for the period.

Despite the positive net income, the results were slightly below analysts' projections, as the consensus from four Zacks Investment Research analysts anticipated earnings of 23 cents per share.

Esperion's quarterly revenue reached $168.4 million, surpassing the average forecast of $160.6 million from three Zacks analysts.

Over the full year, Esperion reported a net loss totaling $22.7 million, or 11 cents per share, with annual revenue amounting to $403.1 million.

Financial data for this article was compiled by Automated Insights using information from Zacks Investment Research.